Oxford BioDynamics Plc (OXBOF)
OTCMKTS · Delayed Price · Currency is USD
0.0020
-0.0015 (-42.86%)
At close: Jan 23, 2026
Oxford BioDynamics Employees
Oxford BioDynamics had 41 employees as of September 30, 2025. The number of employees decreased by 10 or -19.61% compared to the previous year.
Employees
41
Change
-10
Growth
-19.61%
Revenue / Employee
$35,900
Profits / Employee
-$365,654
Market Cap
18.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 41 | -10 | -19.61% |
| Mar 31, 2025 | 44 | - | - |
| Sep 30, 2024 | 51 | 6 | 13.33% |
| Sep 30, 2023 | 45 | 1 | 2.27% |
| Sep 30, 2022 | 44 | 5 | 12.82% |
| Sep 30, 2021 | 39 | 2 | 5.41% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Centogene | 384 |
| Interpace Biosciences | 111 |
| Psychemedics | 101 |
| Aspira Women's Health | 66 |
| Longduoduo Company | 52 |
| Hypha Labs | 5 |
Oxford BioDynamics News
- 1 year ago - Oxford Biodynamics to present on its line of EpiSwitch® products for companion diagnostics in cancer immunotherapy at the 14th World Summit for Clinical Biomarkers and Companion Diagnostics in Boston, MA. - Business Wire
- 1 year ago - Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy - Business Wire